This book tells a story of Polish and Slovak Holocaust survivors returning to homes that no longer existed in the aftermath of the Second World War. It focuses on their daily efforts to rebuild their lives in the radically changed political and social landscape of post-war Eastern Europe. Such an analysis shifts the perspective from post-war violence and emigration to post-war reconstruction. Using a comparative approach, Anna Cichopek-Gajraj discusses survivors' journeys home, their struggles to retain citizenship and repossess property, their coping with antisemitism, and their efforts to return to 'normality'. She emphasizes the everyday communal and personal experiences of survivors in the context of their relationships with non-Jews. In essence, by focusing on the daily efforts of Polish and Slovak Jews to rebuild their lives, the author investigates the limits of belonging in Eastern Europe after the Holocaust.
After the Second World War, the Czechoslovak state redrew the boundaries around its national/ethnic community, defining anew who belonged and who did not. This process primarily involved the redefinition of the criteria for citizenship. Jewish survivors were among those who negotiated for the recognition of their citizenship. Since the Czechoslovak government did not grant Jews legal status as a national minority, Jewish survivors could be freely classified as Slovaks, Czechs, Germans, or Magyars. The latter two translated into refusal of citizenship and expulsion. This article discusses how Magyar-speaking Jews in Slovakia struggled to secure Czechoslovak citizenship through dialogue and conflict between their representatives, local administrations, and the central government.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.